SymBiosis Capital Management, LLC is a biotechnology-focused investment firm. While all investments carry risk of loss, private investments, including venture capital funds, carry a greater risk due to a number of factors, including, but not limited to: the age of the company, its financial history, the industry in which it operates, the experience of management, limited or nonexistent liquidity, restrictions on resale of the investment, and many other factors.

It is strongly suggested that each user seek their own independent advice in relation to any investment, financial, legal, tax, accounting or regulatory issues discussed herein. Analyses and opinions contained herein may be based on assumptions that if altered can change the analyses or opinions expressed.  Nothing contained herein shall constitute any representation or warranty as to future performance of any financial instrument, credit, currency rate or other market or economic measure.

The information on this website is for informational purposes only and in no way should be considered an offer to sell or a solicitation of any offer to buy an interest in any investment. Any such offer or solicitation will be made only by means of offering documents relating to the particular investment. Accredited investors interested in SymBiosis’ funds should carefully review these offering documents and confer with their financial adviser, accountant, or legal counsel before investing. SymBiosis may make changes to its business plan or terms at its discretion.